Aandeel TWGL 20/20 GLOBAL, INC.
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren
Inactief instrument

Andere talen 20/20 Global, Inc. Other OTC

Aandelen

TWGL

US90138D1072

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!
Gratis inschrijven
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Mycotopia Therapies Acquires AI Robotics Assets with a Total Transaction Value of $9 Million
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Mycotopia Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Mycotopia Therapies : Non-Reliance on Previously Issued Financial Report - Form 8-K
MYCOTOPIA THERAPIES, INC. : Non-Reliance on Previous Financials, Audits or Interim Review (form 8-K)
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION (form 10-K)
Mycotopia Therapies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Mycotopia Therapies, Inc. Auditor Raises 'Going Concern' Doubt
MYCOTOPIA THERAPIES, INC. : Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
PSLY.com, Inc. Ei.Ventures, Inc. and Mycotopia Therapies Inc. Terminate Agreement and Plan of Merger
Ei.Ventures, Inc. cancelled the acquisition of Mycotopia Therapies Inc. from EHAVE, Inc. (OTCPK:EHVV.F) and others in a reverse merger transaction.
Ehave Shareholder from CEO Ben Kaplan and Corporate Update
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Mycotopia Therapies, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Mycotopia Therapies, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
MYCOTOPIA THERAPIES, INC. MANAGEMENT'S DISCUSSION AND ANLAYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers TPIA
  4. Koers TWGL
  5. Nieuws 20/20 Global, Inc.
  6. Andere talen